Home Current Issue Previous Issues Published Ahead-of-Print For Authors Journal Info
Skip Navigation LinksHome > July 2006 - Volume 48 - Issue 1 > Linalyl Acetate as a Major Ingredient of Lavender Essential...
Journal of Cardiovascular Pharmacology:
July 2006 - Volume 48 - Issue 1 - pp 850-856
doi: 10.1097/01.fjc.0000238589.00365.42
Original Article

Linalyl Acetate as a Major Ingredient of Lavender Essential Oil Relaxes the Rabbit Vascular Smooth Muscle through Dephosphorylation of Myosin Light Chain

Koto, Ruriko MS; Imamura, Masatoshi MD; Watanabe, Chie; Obayashi, Satoshi MD, PhD; Shiraishi, Mitsuya PhD; Sasaki, Yasuharu PhD; Azuma, Hiroshi PhD

Collapse Box

Abstract

In a preliminary experiment, we found that lavender essential oil relaxes vascular smooth muscle. Thus, the present experiments were designed to investigate the relaxation mechanism of linalyl acetate as the major ingredient of lavender essential oil in rabbit carotid artery specimens. Linalyl acetate produced sustained and progressive relaxation during the contraction caused by phenylephrine. The relaxation effect of linalyl acetate at a concentration near the EC50 was partially but significantly attenuated by nitroarginine as an inhibitor of nitric oxide synthase, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxaline-1-one as an inhibitor of guanylyl cyclase, or by the denudation of endothelial cells. In specimens without endothelium, the phenylephrine-induced contraction and phosphorylation of myosin light chain (MLC) were significantly attenuated after the pretreatment with linalyl acetate. The relaxation caused by linalyl acetate in the endothelium-denuded specimens was clearly inhibited by calyculin A as an inhibitor of MLC phosphatase, although not by ML-9 as an inhibitor of MLC kinase. Furthermore, suppression of the phenylephrine-induced contraction and MLC phosphorylation with linalyl acetate was canceled by the pretreatment with calyculin A. These results suggest that linalyl acetate relaxes the vascular smooth muscle through partially activation of nitric oxide/cyclic guanosine monophosphate pathway, and partially MLC dephosphorylation via activating MLC phosphatase.

© 2006 Lippincott Williams & Wilkins, Inc.

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.